Assoc. Prof. RIDVAN KARAALİ

Publication Network

Articles 87

1. Fever of unknown origin (FUO): a 7-year clinical experience, etiological distribution, and diagnostic approaches

Kaya M. S., YILDIZ KAYA S., KARAALİ R., Can G., BALKAN İ. İ., Mete B., et al.

BMC INFECTIOUS DISEASES , vol.25, no.1, 2025 (SCI-Expanded, Scopus)

2. Cognitive impairments, depression and quality of life 1 year after COVID-19 hospital discharge

poyraz c. a., bostan B. U., Çelik E. B. E., Hacısalihoğlu İ., Kirpinar M., POYRAZ B. Ç., et al.

Cukurova Medical Journal , vol.50, no.2, pp.328-340, 2025 (ESCI, TRDizin)

3. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach.

DİRİCAN E., Bal T., Onlen Y., Sarigul F., User U., Sari N. D., et al.

Journal of clinical laboratory analysis , vol.39, no.12, 2025 (SCI-Expanded, Scopus)

4. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Loiodice A., Bailly S., Ruckly S., Buetti N., Barbier F., Staiquly Q., et al.

Clinical Microbiology and Infection , vol.30, no.12, pp.1559-1568, 2024 (SCI-Expanded)

5. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study

Margalit I., Yahav D., Hoffman T., Tabah A., Barbier F., Singer P., et al.

Infection , vol.52, no.6, pp.2435-2443, 2024 (SCI-Expanded, Scopus)

6. Antibody responses post-booster COVID-19 vaccination: Insights from a single-center prospective cohort study

Dinc H., CAN G., BUDAK B., Dasdemir F., KESKİN E., Kirkoyun-Uysal H., et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , vol.110, no.2, 2024 (SCI-Expanded, Scopus)

7. Resistance Genes and Mortality in Carbapenem-resistant Klebsiella pneumoniae Bacteremias: Effects of the COVID-19 Pandemic

KURT A. F., Tanriverdi E. S., YALÇIN M., Bayramlar O. F., YILDIZ KAYA S., KARAALİ R., et al.

BALKAN MEDICAL JOURNAL , vol.41, no.5, pp.357-368, 2024 (SCI-Expanded, Scopus)

8. Cell free DNA as a new prognostic biomarker for COVID-19, A prospective cohort study

Erdem H., BALKAN İ. İ., KARAALİ R., Ürkmez S., METE B., AYGÜN G., et al.

Diagnostic Microbiology and Infectious Disease , vol.110, no.1, 2024 (SCI-Expanded, Scopus)

9. Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)

Somayaji R., Luke D. R., Lau A., Guner R., TABAK Ö. F., Hepokoski M., et al.

BMJ OPEN , vol.14, no.3, 2024 (SCI-Expanded, Scopus)

10. Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration

Caglar B., Durcan E., Karaali R., Balkan İ. İ., Kaya S., Yavuzer H., et al.

CURRENT HIV RESEARCH , vol.22, no.1, pp.65-71, 2024 (SCI-Expanded, Scopus) Sustainable Development

11. Increased prevalence of mild myopathic changes in the post-COVID-19 duration

GÜNDÜZ A., Ser M. H., Çalıkuşu F. Z., Tanrıverdi U., Abbaszade H., Hakyemez S., et al.

Neurological Research , vol.46, no.2, pp.111-118, 2024 (SCI-Expanded, Scopus)

12. Urinary tract infections in older adults: associated factors for extended-spectrum beta-lactamase production

Alkan S., BALKAN İ. İ., Surme S., Bayramlar O. F., Kaya S., KARAALİ R., et al.

FRONTIERS IN MICROBIOLOGY , vol.15, 2024 (SCI-Expanded, Scopus)

13. Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients: Real-Life Data of 20 Years.

Mete B., Kaya S., Kaya A., Kurt A. F., Bayramlar O. F., Karaali R., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.11, pp.1163-1170, 2023 (SCI-Expanded, Scopus, TRDizin)

14. Increase in transaminase levels during COVID-19 infection and its association with poor prognosis

Bakkaloglu O. K., Onal U., Eskazan T., Kurt E. A., Candan S., Karaali R., et al.

SINGAPORE MEDICAL JOURNAL , vol.64, no.10, pp.640-644, 2023 (SCI-Expanded, Scopus) Sustainable Development

15. Performance of noninvasive fibrosis indices in chronic hepatitis B during pretreatment and post-treatment periods

Ozdemir Y. E., Ozdemir M. S., Bayramlar O. F., YILDIZ KAYA S., KARAALİ R., BALKAN İ. İ., et al.

BIOMARKERS IN MEDICINE , vol.17, no.19, pp.799-809, 2023 (SCI-Expanded, Scopus)

16. Homologous or heterologous COVID-19 vaccine schemes: comparison of immune responses and side effects.

KARAALİ R., Öykü Dinç H. Ö., İnanç Balkan İ., Can G., Keskin E., Çolak H., et al.

Diagnostic microbiology and infectious disease , vol.107, no.2, pp.116017, 2023 (SCI-Expanded, Scopus)

17. Six-month psychiatric outcomes among survivors of COVID-19

aksoy poyraz c., demirel o. f., POYRAZ B. Ç., Turan Ş., Bulu E., OSMANLI SHIROLU S., et al.

Cukurova Medical Journal , vol.48, no.3, pp.759-771, 2023 (ESCI, TRDizin)

18. Morbidity and Mortality in Immunocompromised COVID-19 Patients: Which Factors Are Responsible? Bağışıklığı Baskılanmış Hastalarda COVID-19 İnfeksiyonuna Bağlı Morbidite ve Mortalite: Hangi Faktörler Etkili?

KARAALİ R., Sak K., Uygur A., Hakyemez F. S., Yıldız-Kaya S., Tabak F.

Klimik Dergisi , vol.36, no.3, pp.208-215, 2023 (ESCI, Scopus, TRDizin)

19. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study

Erdem H., Kocoglu E., ANKARALI H., El-Sokkary R., Hakamifard A., KARAALİ R., et al.

International Journal of Antimicrobial Agents , vol.62, no.3, 2023 (SCI-Expanded, Scopus)

20. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study

Karaali R.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.78, no.7, pp.1757-1768, 2023 (SCI-Expanded, Scopus)

21. Talaromyces marneffei infection in an HIV infected patient with hematological malignancy - first report from Turkey

Kurt A. F., Cicek E., Alhelou T. A. M., Mete B., Karaali R., Kuskucu M. A., et al.

NEW MICROBIOLOGICA , vol.46, no.3, pp.311-314, 2023 (SCI-Expanded, Scopus) Sustainable Development

22. Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission

KURT E. A., BAKKALOĞLU O. K., EŞKAZAN T., AKDOGAN S., ÖNAL U., CANDAN S., et al.

Turkish Journal of Gastroenterology , vol.34, no.4, pp.322-331, 2023 (SCI-Expanded, Scopus, TRDizin)

23. Long-term follow-up of treatment-naive HBeAg-negative patients with chronic hepatitis B

ÖZDEMİR Y. E., Ozdemir M., Bayramlar O. F., SÜRME S., Kaya S., KARAALİ R., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , vol.192, no.2, pp.633-639, 2023 (SCI-Expanded, Scopus) Sustainable Development

24. Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required

BALKAN İ. İ., DİNÇ H. Ö., CAN G., KARAALİ R., Ozbey D., ÇAĞLAR B., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , vol.192, no.1, pp.19-25, 2023 (SCI-Expanded, Scopus)

25. Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers

Çulpan H. C., Aydın S. N., Uygur A., SAYILI U., Şeker E., BALKAN İ. İ., et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.19, no.3, 2023 (SCI-Expanded, Scopus)

26. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Karaali R.

INTENSIVE CARE MEDICINE , vol.1, no.49, pp.178-190, 2023 (SCI-Expanded, Scopus)

27. Autonomic and neuropathic complaints of long-COVID objectified: an investigation from electrophysiological perspective

SER M. H., Calikusu F. Z., TANRIVERDİ U., Abbaszade H., Hakyemez S., BALKAN İ. İ., et al.

NEUROLOGICAL SCIENCES , vol.43, no.11, pp.6167-6177, 2022 (SCI-Expanded, Scopus)

28. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey.

Sarıgül Yıldırım F., Üser Ü., Sarı N. D., Kurtaran B., Önlen Y., Şenateş E., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.11, pp.971-978, 2022 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

29. Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs

SALTOĞLU N., DİNÇ H. Ö., BALKAN İ. İ., CAN G., Ozbey D., BEYTUR A. N., et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , vol.104, no.2, 2022 (SCI-Expanded, Scopus) Sustainable Development

30. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey.

Onlen Y., , Bal T., Cabalak M., Oztoprak N. C., Sari N. D., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.10, pp.862-873, 2022 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

31. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study.

Kurt A. F., Mete B., Urkmez S., Demirkiran O., Dumanli G. Y., Bozbay S., et al.

Journal of intensive care medicine , vol.37, no.10, pp.1353-1362, 2022 (SCI-Expanded, Scopus) Sustainable Development

32. Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

Buetti N., Tabah A., Loiodice A., Ruckly S., Aslan A. T., Montrucchio G., et al.

CRITICAL CARE , vol.26, no.1, 2022 (SCI-Expanded, Scopus)

33. Changing Bacterial Etiology and Antimicrobial Resistance Profiles as Prognostic Determinants of Diabetic Foot Infections: A Ten-Year Retrospective Cohort Study

Surme S., Saltoglu N., Kurt A. F., Karaali R., Balkan İ. İ., Baghaki S., et al.

SURGICAL INFECTIONS , vol.23, no.7, pp.667-674, 2022 (SCI-Expanded, Scopus) Sustainable Development

34. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey

Karaali R.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.15, no.9, pp.950-954, 2022 (SCI-Expanded, Scopus)

35. Association of SARS-CoV-2 IgG Antibody Levels with Clinical/Laboratory Characteristics in COVID-19 Patients: Data from a Turkish Study.

Karaali R., Dinc H., Ozdemir Y., Dalar Z., Kurt A. F., Aktas A., et al.

Clinical laboratory , vol.68, no.9, 2022 (SCI-Expanded, Scopus) Sustainable Development

36. Analysis of neurology consultations in hospitalized patients with COVID-19

Ser M. H., Tanrıverdi U., Özkara Ç., Saip S., Aliş C., Güleç Z. E., et al.

ACTA NEUROLOGICA BELGICA , no.4, pp.1011-1018, 2022 (SCI-Expanded, Scopus)

37. SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly

Dinc H. O., Balkan İ. İ., Budak B., Demirci M., Ozbey D., Karaali R., et al.

Infectious Diseases and Clinical Microbiology , vol.4, no.2, pp.129-132, 2022 (ESCI, TRDizin) Sustainable Development

38. Antibody responses to inactivated SARS-CoV-2 vaccine in peritoneal dialysis patients

MURT A., Altiparmak M. R., Ozbey D., Yalin S. F., Sert Yadigar S., KARAALİ R., et al.

SEMINARS IN DIALYSIS , vol.35, pp.264-268, 2022 (SCI-Expanded, Scopus) Sustainable Development

39. The Bad Bug is Back: Acinetobacter Baumannii Bacteremia Outbreak during the COVID-19 Pandemic in an Intensive Care Unit

Mete B., Kurt A. F., Urkmez S., Demirkiran O., Can G., Yartaş Dumanlı G., et al.

Nigerian Journal of Clinical Practice , vol.25, no.5, pp.702-709, 2022 (SCI-Expanded, Scopus) Sustainable Development

40. Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study

DİNÇ H. Ö., Demirci M., Ozdemir Y. E., Sirekbasan S., Aktas A. N., KARAALİ R., et al.

BALKAN MEDICAL JOURNAL , vol.39, no.3, pp.172-177, 2022 (SCI-Expanded, Scopus, TRDizin)

41. Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.

Can G., Acar H. C., Aydin S. N., Balkan İ. İ., Karaali R., Budak B., et al.

Vaccine , vol.40, no.18, pp.2574-2579, 2022 (SCI-Expanded, Scopus) Sustainable Development

42. A 5-year surveillance of healthcare-associated infections in a university hospital: A retrospective analysis

Erdem I., Yildirim I., Safak B., KARAALİ R., Erdal B., Ardic E., et al.

SAGE OPEN MEDICINE , 2022 (ESCI) Sustainable Development

43. Clinical outcomes of geriatric patients with COVID-19: review of one-year data

Ulugerger Avci G., Bektan Kanat B., Suzan V., Can G., Korkmazer B., Karaali R., et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH , vol.34, no.2, pp.465-474, 2022 (SCI-Expanded, Scopus)

44. Acute Kidney Injury in Cases of COVID-19 Without Existing Kidney Disease: Does It Differ at Various Stages of the Disease?

Murt A., , Dincer M. T., Karaca C., Trabulus S., Karaali R., et al.

Cerrahpaşa Medical Journal , vol.46, no.1, pp.35-43, 2022 (TRDizin) Sustainable Development

45. Detection of SARS-CoV-2 RNA in Upper Respiratory Swap Samples by Pooling Method.

Tok Y., Kuşkucu M. A., Erdem H., Sarıbal D., Salman Yılmaz S., Nohut O. K., et al.

Balkan medical journal , vol.39, no.1, pp.48-54, 2022 (SCI-Expanded, Scopus)

46. Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.

Dinc H. O., Saltoglu N., Can G., Balkan İ. İ., Budak B., Ozbey D., et al.

Vaccine , vol.40, no.1, pp.52-58, 2022 (SCI-Expanded, Scopus) Sustainable Development

47. Remdesivir treatment for patients with moderate to severe COVID-19

Karaali R.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.880-887, 2022 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

48. COVID-19 Transmission in Healthcare Professionals in the First Period of the Pandemic

ATEŞ N., AYGÜN G., AYGÜN P., ÇARKI A., CENGİZ S., Alisha L., et al.

KLIMIK JOURNAL , vol.35, no.4, pp.244-248, 2022 (ESCI, Scopus, TRDizin)

49. Predictors of Long-term Outcomes in the Older Adults with Community-Acquired Pneumonia

Surme S., Balkan İ. İ., Bayramlar O. F., Ali R., Mete B., Tabak F., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.15, no.12, pp.1910-1916, 2021 (SCI-Expanded, Scopus)

50. Effects of hypertonic alkaline nasal irrigation on COVID-19

YILMAZ Y. Z., Yilmaz B. B., Ozdemir Y. E., Kocazeybek B. S., KARAALİ R., Cakan D., et al.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY , vol.6, no.6, pp.1240-1247, 2021 (SCI-Expanded, Scopus)

51. COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience.

Kara Esen B., Can G., Pirdal B. Z., Aydin S. N., Ozdil A., Balkan İ. İ., et al.

Vaccines , vol.9, no.11, 2021 (SCI-Expanded, Scopus)

52. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey.

El-Sokkary R., Uysal S., Erdem H., Kullar R., Pekok A. U., Amer F., et al.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology , vol.40, pp.2323-2334, 2021 (SCI-Expanded, Scopus)

53. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19

Gemicioglu B., Uzun H., Borekci Ş., Karaali R., Kurugoglu S., Atukeren P., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.15, no.10, pp.1415-1425, 2021 (SCI-Expanded, Scopus)

54. The role of FDG-PET/CT in HIV-associated fever of unknown origin

Erdem H., Aktas A., Beytur F., KARAALİ R., Mete B., Sonmezoglu K., et al.

HIV MEDICINE , vol.22, pp.181-182, 2021 (SCI-Expanded, Scopus) Sustainable Development

55. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae

BALKAN İ. İ., Alkan M., Aygun G., Kuskucu M., Ankarali H., Karagoz A., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.10, pp.2161-2170, 2021 (SCI-Expanded, Scopus)

56. Presence of Antibodies to SARS-CoV-2 in Domestic Cats in Istanbul, Turkey, Before and After COVID-19 Pandemic

Yilmaz A., Kayar A., Turan N., Iskefli O., Bayrakal A., Roman-Sosa G., et al.

FRONTIERS IN VETERINARY SCIENCE , vol.8, 2021 (SCI-Expanded, Scopus)

57. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study

Erdem H., Hargreaves S., ANKARALI H., ÇAŞKURLU H., Ceviker S. A., Bahar-Kacmaz A., et al.

JOURNAL OF CHEMOTHERAPY , vol.33, no.5, pp.302-318, 2021 (SCI-Expanded, Scopus) Sustainable Development

58. Tocilizumab in COVID-19: The Cerrahpas , a-PREDICT score

Eşkazan A. E., Balkan İ. İ., Demirbaş K. C., Ar M. C., Karaali R., Sekibağ Y., et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY , vol.27, no.9, pp.1329-1335, 2021 (SCI-Expanded, Scopus)

59. The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-gamma Release Assay Results

Borekci Ş., Karakas F. G., Sirekbasan S., Kubat B., Karaali R., Can G., et al.

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY , vol.2021, 2021 (SCI-Expanded, Scopus)

60. COVID-19 and Plasmodium ovale Malaria: A Rare Case of Co-Infection

ÇAĞLAR B., KARAALİ R., BALKAN İ. İ., METE B., AYGÜN G.

KOREAN JOURNAL OF PARASITOLOGY , vol.59, no.4, pp.399-402, 2021 (SCI-Expanded, Scopus) Sustainable Development

61. Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia

Ozdemir Y. E., Balkan İ. İ., Bayramlar O. F., Alkan S., Murt A., Karaali R., et al.

MIKROBIYOLOJI BULTENI , vol.55, no.3, pp.342-356, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

62. Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study

GÖZEN TAN E. D., Aliyeva C., Tevetoğlu F., Karaali R., BALKAN İ. İ., YENER H., et al.

Ear, Nose and Throat Journal , vol.100, no.2_suppl, 2021 (SCI-Expanded, Scopus) Sustainable Development

63. [Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients].

Dinç H. Ö., Özdemir Y. E., Alkan S., Güngördü Dalar Z., Gareayaghi N., Sirekbasan S., et al.

Mikrobiyoloji bulteni , vol.55, no.2, pp.207-222, 2021 (SCI-Expanded, Scopus, TRDizin)

64. Characteristics and outcomes of COVID-19 inpatients who underwent psychiatric consultations

Turan S., Poyraz B. Ç., Aksoy Poyraz C., Demirel Ö. F., Tanrıöver Aydın E., Uçar Bostan B., et al.

ASIAN JOURNAL OF PSYCHIATRY , vol.57, 2021 (SCI-Expanded, Scopus)

65. Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey

Alkurt G., MURT A., Aydin Z., Tatli O., Agaoglu N. B., Irvem A., et al.

PLOS ONE , vol.16, no.3, 2021 (SCI-Expanded, Scopus) Sustainable Development

66. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital.

Acar H. C., Can G., Karaali R., Börekçi Ş., Balkan İ. İ., Gemicioğlu B., et al.

BMC infectious diseases , vol.21, no.1, pp.148, 2021 (SCI-Expanded, Scopus) Sustainable Development

67. Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience)

Mete B., Zerdali E. Y., AYGÜN G., Saltoglu N., Balkan I. I., Karaali R., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.2, pp.325-333, 2021 (SCI-Expanded, Scopus)

68. Psychiatric morbidity and protracted symptoms after COVID-19.

Poyraz B. Ç., Poyraz C., Olgun Y., Gürel Ö., Alkan S., Özdemir Y. E., et al.

Psychiatry research , vol.295, pp.113604, 2021 (SCI-Expanded, SSCI, Scopus) Sustainable Development

69. A 5- Year Surveillance of Nosocomial Infections in a University Hospital: A Retrospective Analysis

Erdem I., Yildirim I., Safak B., Karaali R., Erdal B., Ardic E., et al.

SAGE Open Medicine , vol.10, pp.1-7, 2021 (Scopus)

70. Factors affecting mortality in geriatric patients hospitalized with COVID-19

Bağ Soytaş R., Ünal D., Arman P., Suzan V., Emiroğlu Gedik T., Can G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.2, pp.454-463, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

71. Kidney function on admission predicts in-hospital mortality in COVID-19.

TRABULUS S., KARACA C., BALKAN İ. İ., DİNCER M. T., MURT A., Ozcan Ş. G., et al.

PloS one , vol.15, no.9, 2020 (SCI-Expanded, Scopus) Sustainable Development

72. Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection

DOĞAN M., TOPÇU B., Karaali R., ERDEM İ.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.26, no.2, pp.43-48, 2020 (ESCI, TRDizin) Sustainable Development

73. An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.

KARA ALI R., SÜRME S., BALKAN İ. İ., SALİHOĞLU A., Ozdemir M., Ozdemir Y., et al.

Annals of hematology , vol.99, no.8, pp.1925-1932, 2020 (SCI-Expanded, Scopus)

74. RENAL TRANSPLANTASYON, Böbrek Nakli ve Hepatit

TABAK Ö. F., KARAALİ R.

Türkiye Klinikleri Sağlık Bilimleri Dergisi , 2020 (TRDizin)

75. A Case of Acute Cholestatic Hepatitis Due to Epstein-Barr Virus Infection

Ardic E., Karaali R., Yagmur O., Atar R. V., Kardan M. E., Dogan M., et al.

KLIMIK JOURNAL , vol.33, no.1, pp.100-102, 2020 (ESCI, Scopus) Sustainable Development

76. SARS-CoV-2 Nedir, Bu Güne Nasıl Geldik?

KURT A. F., KARAALİ R.

Medical Research Reports , 2020 (Peer-Reviewed Journal)

77. INDEPENDENT PROGNOSTIC INDICATORS IN THE ELDERLY WITH PNEUMONIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY

SÜRME S., BALKAN İ. İ., Bayramlar O. F., Karaali R., METE B., CAN G., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , vol.23, no.3, pp.342-352, 2020 (SCI-Expanded, SSCI, Scopus, TRDizin)

78. Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences

Ormeci N., Sezgin O., Karaali R., AYGEN B., Turan D., Yaras S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.4, pp.534-539, 2019 (SCI-Expanded, Scopus) Sustainable Development

79. İnvaziv Aspergilloz Tedavisi

Karaali R.

Namık Kemal Tıp Dergisi , vol.6, no.2, pp.64-82, 2018 (TRDizin)

80. Community-acquired Lower Urinary Tract Infections: Etiology, Antimicrobial Resistance, and Treatment Results in Female Patients

Erdem I., Ali R., Ardic E., Omar S. E., Mutlu R., Topkaya A. E.

JOURNAL OF GLOBAL INFECTIOUS DISEASES , vol.10, no.3, pp.129-132, 2018 (ESCI, Scopus)

81. İNVAZİV ASPERGİLLOZ TEDAVİSİ

ERDEM İ., DOĞAN M., KARAALİ R., ELBASAN Ş., ARDIÇ E.

Namık Kemal Tıp Dergisi , vol.6, pp.64-82, 2018 (TRDizin)

82. A rare cause of fever in an adult: a case of familial Mediterranean fever

Erdem I., Saritas F., Karaali R., Ardic E., Emeksiz G. K., Kara S. P., et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , vol.11, pp.37-40, 2018 (ESCI, Scopus)

83. An unusual presentation of brucellosis: hepatic microabscesses

Erdem I., Ali R., Elbasan S., Ozcaglayan O., Degirmenci P. O., Sedef S., et al.

CLINICAL CASE REPORTS , vol.5, no.3, pp.229-231, 2017 (ESCI, Scopus)

84. A Skin Tuberculosis Case: Scrofuloderma

Karaali R.

TURKIYE KLINIKLERI DERMATOLOJI , vol.2, no.1, pp.45-48, 2017 (Scopus) Sustainable Development

85. Streptococcus pneumoniae sepsis as the initial presentation of systemic lupus erythematosus

Erdem I., Omar S. E., Ali R., Gunes H., Topkaya A. E.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE , vol.9, pp.315-317, 2016 (ESCI, Scopus)

86. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities

Saltoglu N., Karali R., Yemisen M., Ozaras R., Balkan İ. İ., Mete B., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.69, no.7, pp.766-770, 2015 (SCI-Expanded, Scopus)

87. Unusual Presentation of Streptococcus anginosus With Severe Sepsis, Liver Abscess Secondary to Biliary Tract Perforation

Karaali R.

Journal of Medical Cases , vol.6, no.11, pp.508-511, 2015 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences 9

1. Performance Comparison of Oral, Laryngeal and Thoracic Sounds in the Detection of COVID-19 by Employing Machine Learning Techniques Oral, Larengeal ve Torakal Konuşma Seslerinin COVID-19 Tespitindeki Performanslarinin Yapay Öǧrenme Yöntemleriyle Karşilaştirilmasi

Gozuacik N., Serbes G., Kara E., Atas E., Okan Sakar C., Murat Yener H., et al.

30th Signal Processing and Communications Applications Conference, SIU 2022, Safranbolu, Turkey, 15 - 18 May 2022, (Full Text)

2. Hipertonik Alkali Nazal Solüsyonun Covid-19 Üzerine Etkisi

YILMAZ Y. Z., YILMAZ B. B., ÖZDEMİR Y. E., KOCAZEYBEK B. S., KARAALİ R., ÇAKAN D., et al.

42. TÜRK ULUSAL KBB VE BAŞ-BOYUN CERRAHİSİ KONGRESİ, Turkey, 3 - 07 November 2021, (Summary Text) Sustainable Development

3. Predictors of long-term outcomes in older adults with community-acquired pneumonia

SÜRME S., BALKAN İ. İ., Bayramlar O., KARAALİ R., METE B., TABAK Ö. F., et al.

31th ECCMID 2021, 9 - 12 July 2021, (Full Text)

4. Needlestick still on the stage: lessons from 444 occupational injuries in a university hospital

BUDAK B., SÜRME S., Özdemir N., Küçükboyacı N., BALKAN İ. İ., KARAALİ R., et al.

31th ECCMID, 9 - 12 July 2021, pp.1150, (Full Text)

5. Sağlık Çalışanlarında İnaktif CoronaVac Aşısının Etkinliği: İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi Verileri

Dinç H. Ö., Budak B., Özbey D., Tok Y., Karaali R., Çağlar B., et al.

XXI. TÜRK KLİNİK MİKROBİYOLOJİ VE İNFEKSİYON HASTALIKLARI KONGRESİ, İstanbul, Turkey, 26 - 30 May 2021, pp.500-501, (Summary Text) Sustainable Development